Filing Details
- Accession Number:
- 0001104659-22-061939
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-05-17 16:09:01
- Reporting Period:
- 2022-05-14
- Accepted Time:
- 2022-05-17 16:09:01
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1526119 | Verastem Inc. | VSTM | Pharmaceutical Preparations (2834) | 273269467 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1563202 | Dan Paterson | C/O Verastem, Inc., 117 Kendrick St., Suite 500 Needham MA 02494 | President And Coo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-05-14 | 15,000 | $0.00 | 492,933 | No | 4 | A | Direct | |
Common Stock | Disposition | 2022-05-16 | 4,988 | $1.03 | 487,945 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | S | Direct |
Footnotes
- - Represents performance-based restricted stock units ("PRSUs") granted to the Reporting Person on June 24, 2021 under the Issuer's 2021 Equity Incentive Plan. Each PRSU represents the right to receive one share of Common Stock. On May 14, 2022 the Compensation Committee of the Issuer's Board of Directors certified that the PRSUs' performance criteria had been satisfied and the PRSUs vested in full.
- - The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units.